Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Other hematologic neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, Mantle-Cell 15Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 5Lymphoma 5Lymphoma, B-Cell 3Leukemia, B-Cell 3Waldenstrom Macroglobulinemia 2Lymphatic Diseases 2Neoplasms 1Neoplasm, Residual 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic 1Leukemia, Hairy Cell 1Hodgkin Disease 1Hematologic Diseases 1Heart Failure 1Glioblastoma 1Burkitt Lymphoma 1Anemia, Hemolytic, Autoimmune 1

Interventions

Rituximab 9venetoclax 7ibrutinib 7Cyclophosphamide 7Mycophenolic Acid 5fludarabine phosphate 4Whole-Body Irradiation 4Sirolimus 4zanubrutinib 3pirtobrutinib 3Peripheral Blood Stem Cell Transplantation 3Dexamethasone 3Cyclosporine 3ixazomib 2fludarabine 2carfilzomib 2acalabrutinib 2Tacrolimus 2Melphalan 2Etoposide 2Cyclosporins 2Calcium Dobesilate 2CT-P10 2Busulfan 2Bendamustine Hydrochloride 2talquetamab 1pembrolizumab 1loncastuximab tesirine 1brexucabtagene autoleucel 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Waldenstrom Macroglobulinemia × acalabrutinib × 90 days × Clear all
NCT02362035 2026-05-13

KEYNOTE145

Acerta Pharma BV

Phase 1/2 Completed
161 enrolled 29 charts
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT02180724 2026-03-20

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Acerta Pharma BV

Phase 2 Active not recruiting
107 enrolled 15 charts
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡